688 related articles for article (PubMed ID: 21596890)
1. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
2. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
3. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
Lee SJ; Kim SG
Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
[TBL] [Abstract][Full Text] [Related]
4. Arachidonic acid regulation of the cytosolic phospholipase A 2α/cyclooxygenase-2 pathway in mouse endometrial stromal cells.
Zhao ZA; Zhang ZR; Xu X; Deng WB; Li M; Leng JY; Liang XH; Yang ZM
Fertil Steril; 2012 May; 97(5):1199-205.e1-9. PubMed ID: 22369775
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
Cho IJ; Ki SH; Brooks C; Kim SG
Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
[TBL] [Abstract][Full Text] [Related]
6. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
Dent P; Fang Y; Gupta S; Studer E; Mitchell C; Spiegel S; Hylemon PB
Hepatology; 2005 Dec; 42(6):1291-9. PubMed ID: 16317705
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acids.
Erichsen TJ; Aehlen A; Ehmer U; Kalthoff S; Manns MP; Strassburg CP
J Hepatol; 2010 Apr; 52(4):570-8. PubMed ID: 20189675
[TBL] [Abstract][Full Text] [Related]
8. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
Cho IJ; Sung DK; Kang KW; Kim SG
Arch Pharm Res; 2009 Apr; 32(4):625-35. PubMed ID: 19407981
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.
Ko MS; Lee SJ; Kim JW; Lim JW; Kim SG
Drug Metab Dispos; 2006 Aug; 34(8):1353-60. PubMed ID: 16714377
[TBL] [Abstract][Full Text] [Related]
10. Activation of farnesoid X receptor increases the expression of cytokine inducible SH2-containing protein in HepG2 cells.
Xu Z; Huang G; Gong W; Zhao Y; Zhou P; Zeng Y; He F
J Interferon Cytokine Res; 2012 Nov; 32(11):517-23. PubMed ID: 22817871
[TBL] [Abstract][Full Text] [Related]
11. The farnesoid X receptor induces very low density lipoprotein receptor gene expression.
Sirvent A; Claudel T; Martin G; Brozek J; Kosykh V; Darteil R; Hum DW; Fruchart JC; Staels B
FEBS Lett; 2004 May; 566(1-3):173-7. PubMed ID: 15147890
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer-binding protein-β participates in oxidized LDL-enhanced proliferation in 3T3-L1 cells.
Santangelo C; Varì R; Scazzocchio B; Filesi C; D'Archivio M; Giovannini C; Masella R
Biochimie; 2011 Sep; 93(9):1510-9. PubMed ID: 21621583
[TBL] [Abstract][Full Text] [Related]
13. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
[TBL] [Abstract][Full Text] [Related]
14. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
15. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells.
Zhang Q; He F; Kuruba R; Gao X; Wilson A; Li J; Billiar TR; Pitt BR; Xie W; Li S
Cardiovasc Res; 2008 Feb; 77(3):560-9. PubMed ID: 18006431
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor up-regulates expression of lipid transfer inhibitor protein in liver cells and mice.
Li L; Liu H; Peng J; Wang Y; Zhang Y; Dong J; Liu X; Guo D; Jiang Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):880-5. PubMed ID: 24211198
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo.
Wang YD; Yang F; Chen WD; Huang X; Lai L; Forman BM; Huang W
Mol Endocrinol; 2008 Jul; 22(7):1622-32. PubMed ID: 18436567
[TBL] [Abstract][Full Text] [Related]
19. Regulation of activating transcription factor-2 in early stage of the adipocyte differentiation program.
Lee MY; Kong HJ; Cheong J
Biochem Biophys Res Commun; 2001 Mar; 281(5):1241-7. PubMed ID: 11243868
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
